A detailed history of Boston Research & Management Inc transactions in Danaher Corp stock. As of the latest transaction made, Boston Research & Management Inc holds 1,918 shares of DHR stock, worth $452,341. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,918
Previous 2,078 7.7%
Holding current value
$452,341
Previous $519,000 2.7%
% of portfolio
0.13%
Previous 0.13%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$239.25 - $280.76 $38,280 - $44,921
-160 Reduced 7.7%
1,918 $533,000
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $39,529 - $241,184
-160 Reduced 7.15%
2,078 $536,000
Q2 2022

Aug 11, 2022

SELL
$237.11 - $299.66 $11,855 - $14,983
-50 Reduced 2.19%
2,238 $567,000
Q3 2021

Nov 10, 2021

SELL
$272.21 - $332.43 $27,220 - $33,243
-100 Reduced 4.19%
2,288 $696,000
Q3 2021

Nov 10, 2021

BUY
$272.21 - $332.43 $27,220 - $33,243
100 Added 4.37%
2,388 $537,000
Q2 2021

Aug 11, 2021

SELL
$225.08 - $271.69 $22,508 - $27,169
-100 Reduced 4.19%
2,288 $614,000
Q4 2019

Feb 07, 2020

SELL
$133.47 - $153.48 $3,870 - $4,450
-29 Reduced 1.2%
2,388 $366,000
Q3 2017

Nov 09, 2017

BUY
$79.29 - $88.45 $191,643 - $213,783
2,417
2,417 $207,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Boston Research & Management Inc Portfolio

Follow Boston Research & Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Research & Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Boston Research & Management Inc with notifications on news.